In addition, high percentages of CD14+HLA-DR−/low M-MDSCs in patients with hepatocellular carcinoma were shown to induce the production of CD4+CD25+Foxp3+ regulatory T cells [19]. This evidence concerns the gene CD14 and hepatocellular carcinoma.